Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT02045927
Other study ID # E-13-519
Secondary ID
Status Terminated
Phase N/A
First received January 22, 2014
Last updated February 18, 2016
Start date January 2014
Est. completion date December 2015

Study information

Verified date February 2016
Source Englewood Hospital and Medical Center
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

This study looks to assess whether monitoring sedation status in mechanically-ventilated Medical Surgical Intensive Care Unit (MSICU) patients using Bispectral index (BIS) monitor-augmented sedation monitoring as opposed to Richmond Agitation Sedation Scale (RASS) score is associated with decreased duration of mechanical ventilation.

Investigators hypothesize that using BIS monitors to help monitor depth of sedation in mechanically ventilated ICU patient will result in a decreased duration of mechanical ventilation when compared to solely utilizing clinical sedation scales such as RASS.


Description:

Participants will be randomized into two groups, the intervention group will receive sedation monitoring with BIS monitoring plus RASS. The control group will receive sedation monitoring with RASS score only. Randomization will be accomplished through online randomization software.

For randomization purposes, the intervention group will be labeled as the "A" group. The control group will labeled as the "B" group. In the BIS-augmented group, sedation requirement will be titrated according to an average of BIS reading in the 5 minute period prior to assessment with a goal of maintaining a value of (60-70) in addition to a RASS score goal of (-1 to -2), provided no noxious stimulation such as endotracheal suctioning and/or wound dressing has occurred for at least 30 minutes, BIS values have been stable for at least 5 minutes, signal quality index (>80%), minimal EMG interference (<50%), patient is not shivering, and patient does not have warmer or other devices that may produce an electric current on their body or nearby. In the RASS group, sedation requirements will be titrated to maintain a RASS score of (-1 to -2), will be assessed via the nurse taking care of the patient provided no noxious stimulation has occurred for at least 30 minutes prior to assessment.

Both groups will have sedation assessment at least every 6 hours during a 12 hour shift and as needed as per ICU RN and/or physician. Nurses will be free to exercise their judgment if they deem that their patients require more or less sedation that is inconsistent with patient's BIS or RASS score, they will, however, be required to provide a rationale for their judgment and record such events on a special form created for this study.


Recruitment information / eligibility

Status Terminated
Enrollment 19
Est. completion date December 2015
Est. primary completion date June 2015
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patients >18 years of age.

- Patients expected to be mechanically ventilated and sedated with continuous intravenous infusions of Propofol or Midazolam and fentanyl for >= 24 hours within 12 hours of screening.

Exclusion Criteria:

- Patients with Seizure disorders acute neurological injury, severe dementia or anoxic brain injury.

- Patients with tracheostomies.

- Patients requiring neuromuscular blocking agents (NMBA).

- Patients transferred from another ICU while mechanically ventilated.

- Patients with cardiac pacemakers.

- Peri-cardiac arrest patients.

- Patients with induced hypothermia.

- Pregnant patients.

- Patients with no known Legally Authorized Representative (LAR).

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care


Related Conditions & MeSH terms

  • Patients Who Are Mechanically Ventilated and Sedated

Intervention

Other:
sedation monitoring with RASS score

sedation monitoring with BIS-Guided monitoring


Locations

Country Name City State
United States Englewood Hospital and Medical Center Englewood New Jersey

Sponsors (1)

Lead Sponsor Collaborator
Englewood Hospital and Medical Center

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary duration of mechanical ventilation from enrollment to extubation, an expected average of 4 days No
Secondary total sedation medication dose from enrollment until extubation, an expected average of 4 days No
Secondary undersedation measured by self-initiated medical support device removal, time in hours spent in physical restraints, or ventilator asynchrony from enrollment to extubation, an expected average of 4 days No

External Links